Self preserved aqueous pharmaceutical compositions

Details for Australian Patent Application No. 2007299727 (hide)

Owner Alcon Research, Ltd.

Inventors Han, Wesley Wehsin; Schneider, L. Wayne; Chowhan, Masood A.; Kabra, Bhagwati P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007299727

PCT Pub. Number WO2008/036847

Priority 60/826,529 21.09.06 US; 60/827,411 28.09.06 US

Filing date 20 September 2007

Wipo publication date 27 March 2008

Acceptance publication date 6 October 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/036847 Priority application(s): WO2008/036847

9 April 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Alcon Manufacturing, Ltd., Application No. 2007299727, Under INID (71), correct the name to Alcon Research, Ltd.

6 October 2011 Application Accepted

  Published as AU-B-2007299727

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299738-Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief

2007299726-Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis